Filing Details
- Accession Number:
- 0001387131-20-011164
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-16 21:03:18
- Reporting Period:
- 2020-12-14
- Accepted Time:
- 2020-12-16 21:03:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1478320 | Adaptive Biotechnologies Corp | ADPT | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1103804 | Viking Global Investors Lp | 55 Railroad Avenue Greenwich CT 06830 | No | No | Yes | No | |
1132625 | Viking Global Performance Llc | 55 Railroad Avenue Greenwich CT 06830 | No | No | Yes | No | |
1133006 | Andreas Ole Halvorsen | 55 Railroad Avenue Greenwich CT 06830 | No | No | Yes | No | |
1413378 | Viking Global Equities Ii Lp | 55 Railroad Avenue Greenwich CT 06830 | No | No | Yes | No | |
1621596 | Ltd. Master Fund Long Viking | 55 Railroad Avenue Greenwich CT 06830 | No | No | Yes | No | |
1621607 | Viking Long Fund Gp Llc | 55 Railroad Avenue Greenwich CT 06830 | No | No | Yes | No | |
1621842 | C. David Ott | 55 Railroad Avenue Greenwich CT 06830 | No | No | Yes | No | |
1711393 | Sharon Rose Shabet | 55 Railroad Avenue Greenwich CT 06830 | No | No | Yes | No | |
1759530 | Ltd. Master Equities Global Viking | 55 Railroad Avenue Greenwich CT 06830 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-14 | 1,000,000 | $55.65 | 29,993,708 | No | 4 | S | Indirect | See explanation of responses |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See explanation of responses |
Footnotes
- On December 14, 2020, the Viking Funds (defined below) sold an aggregate of 1,000,000 shares of common stock of the Issuer ("Common Stock") at a price of $55.65 per share.VGE II sold 14,671 shares, VGEM sold 718,897 shares and VLFM sold 266,432 shares.
- O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP ("VGI"), Viking Global Performance LLC ("VGP") and Viking Long Fund GP LLC ("VLFGP"). VGI provides managerial services to various investment funds, including Viking Global Equities II LP ("VGE II") and Viking Global Equities Master Ltd. ("VGEM") and Viking Long Fund Master Ltd. ("VLFM" and together with VLFM, VGEM and VGE II, the "Viking Funds").
- VGP is the general partner of VGE II. VLFGP serves as the investment manager of VLFM. Each of the Viking Funds, VGI, VGP, VLFGP, Mr. Halvorsen, Mr. Ott and Ms. Shabet (collectively, the "Reporting Persons") may be deemed to beneficially own the shares reported on this form.
- VGI provides managerial services to (i) VGE II, which directly holds 454,717 shares of Common Stock; (ii) VGEM, which directly holds 22,281,040 shares of Common Stock; and (iii) VLFM, which directly holds 8,257,951 shares of Common Stock. Because of the relationship between VGI and the Viking Funds, VGI may be deemed to beneficially own the shares of Common Stock directly held by the Viking Funds.
- VGP is the general partner of VGE II and the investment manager of VGEM. Because of the relationships between VGP and VGE II and VGEM, respectively, VGP may be deemed to beneficially own the shares of Common Stock directly held by VGE II and VGEM.
- VLFGP serves as the investment manager of VLFM. Because of the relationship between VLFGP and VLFM, VLFGP may be deemed to beneficially own the shares of Common Stock directly held by VLFM.
- The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.